Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

Condition:   Non Small Cell Lung Cancer Intervention:   Sponsor:   Hunan Province Tumor Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials